CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.
James Park
Advertisement
James Park is executive vice-president and managing director of the Global Sales Center at Samsung Biologics.
Articles by James Park
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
5